Oyster Point Pharma, Inc. (OYST), relating to its proposed acquisition by Viatris Inc. Under the terms of the agreement, OYST shareholders will receive $11.00 in cash plus up to $2.00 per share in CVRs per share they own.
Oyster Point Pharma, Inc. (OYST), relating to its proposed acquisition by Viatris Inc. Under the terms of the agreement, OYST shareholders will receive $11.00 in cash plus up to $2.00 per share in CVRs per share they own.